期刊文献+

原发性纵隔B细胞淋巴瘤与非纵隔弥漫性大B细胞淋巴瘤在基因重排检测与EB病毒感染方面的对比研究 被引量:8

Comparative study between primary mediastinal B-cell lymphoma and non-mediastinal diffuse large B-cell lymphoma by immunoglobulin gene rearrangement and Epstein-Barr virus infection detection
原文传递
导出
摘要 目的探讨原发性纵隔B细胞淋巴瘤(PMBCL)与非纵隔弥漫性大B细胞淋巴瘤(DLBCL)在基因重排检测与EB病毒感染方面的差异。方法收集2000年9月至2011年5月北京协和医院手术切除的PMBCL20例,选取同期非纵隔DLBCL30例作为对照,进行回顾性病理学分析并进行重链和轻链基因重排检测、EBER原位杂交检测。结果20例PMBCL中6例基因重排检测呈单克隆性,均为弱阳性条带;30例DLBCL中27例基因重排检测呈单克隆性(90.0%),均为强阳性条带;EBER在20例PMBCL中检测到1例阳性,在30例DLBCL中检测到2例阳性。结论PMBCL在重链和轻链的基因重排检测方面单克隆率低,而非纵隔DLBCL单克隆率高,二者具有显著差异;但原位杂交检测EBER,二者感染率均低,无明显区别。 Objective To investigate the differences between primary mediastinal B-cell lymphoma (PMBCL) and non-mediastinal conventional diffuse large B-cell common lymphoma (DLBCL) in immunoglobulin gene rearrangement and EB virus infections. Methods Twenty cases of PMBCL and 30 cases of non-mediastinal DLBCL were collected from September, 2000 to May, 2011. Pathological data were retrospectively analysed. Immunoglobulin heavy chain and light chain gene rearrangements and EBER in-situ hybridization were performed. Results Six of 20 cases of PMBCL showed monoclonal gene rearrangement, all of which were weakly detected. Twenty-seven of 30 cases of ordinary diffuse large B-cell lymphoma showed monoelonal gene rean'angement, which were strongly detected (90. 0% ). Only 1 of 20 cases PMBCL and 2 of 30 cases of DLBCL were positive for EBER in-situ hybridization. Conclusions The detection rate of immunoglobulin gene rearrangement is significantly lower in PMBCL than that of non-mediastinal DLBCL. However, EB virus infection rates are very low in both types of lymphomas.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2012年第6期361-365,共5页 Chinese Journal of Pathology
关键词 淋巴瘤 B细胞 淋巴瘤 大细胞 弥漫型 纵隔肿瘤 基因重排 Lymphoma, B-cell Lymphoma,large-cell, diffuse Mediastinal neoplasms Gene rearrangement
  • 相关文献

参考文献19

  • 1Swerdlow SH, Campo E, Harris NL, et al, WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press ,2008 : 14-15.
  • 2Miller JB, Variakojis D, Bitran JD, et al. Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstruction. Cancer,1981,47(4) :748- 756.
  • 3Cazals-Hatem D, Lepage E, Briee P, et al. Primary medlastinal large B-cell lylnphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Aduhe") study. Am J Surg Pathol, 1996,20 ( 7 ) : 877 -888.
  • 4Barth TF, Leithauser F, Joos S, et al. Mediastinal (thymic) large B-cell lymphoma: where do we stand? Lancet Oncol,2002,3 (4) : 229-334.
  • 5Savage K J, Al-Rajhi N, Voss N, et al. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann Oncol, 2006,17 ( 1 ) : 123- 130.
  • 6Langerak AW, Molina TJ, Lavender FL, et al. Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-C398-3936. Leukemia, 2007,21 (2) :222-229.
  • 7Shair KH, Bendt KM, Edwards RH,et al. EBV latent membrane protein 1 activates Akt, NFkappaB, and Star3 in B cell lymphomas. PLoS Pathog,2007,3 ( 11 ) : e166.
  • 8van Krieken JH, Langerak AW, Macintyre EA, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98- 3936. Leukemia,2007,21 (2) :201-206.
  • 9Evans PA, Pott Ch, Groenen PJ, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of muhiple immnnoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia, 2007,21 ( 2 ) : 207-214.
  • 10Brandter LB, Smith CI, Hammarstrom L, et al. Clonal immunoglobulin gene rearrangements in primary mediastinal clear cell lymphomas. Leukemia, 1989,3 ( 2 ) : 122 -129.

同被引文献124

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部